These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18592729)

  • 1. [The philosophy of drug firms on drug pricing].
    Jolidon RM
    Rev Med Suisse; 2008 May; 4(159):1358-60. PubMed ID: 18592729
    [No Abstract]   [Full Text] [Related]  

  • 2. Reference pricing and firms' pricing strategies.
    Miraldo M
    J Health Econ; 2009 Jan; 28(1):176-97. PubMed ID: 19038465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mergers in Japan help firms retain own products.
    Fuyuno I
    Nat Rev Drug Discov; 2005 May; 4(5):358. PubMed ID: 15902766
    [No Abstract]   [Full Text] [Related]  

  • 4. EU offers incentives to firms to produce medicines for children.
    Watson R
    BMJ; 2006 Jun; 332(7554):1352. PubMed ID: 16763236
    [No Abstract]   [Full Text] [Related]  

  • 5. Pricing pharmaceutical compounds under development.
    Dimitri N
    Trends Pharmacol Sci; 2014 May; 35(5):217-8. PubMed ID: 24439477
    [No Abstract]   [Full Text] [Related]  

  • 6. Manufacturers urge German government to revise proposals for pricing new drugs.
    Stafford N
    BMJ; 2012 Jun; 344():e4069. PubMed ID: 22695911
    [No Abstract]   [Full Text] [Related]  

  • 7. "Who's winning the human race?"Cold war as pharmaceutical political strategy.
    Tobbell DA
    J Hist Med Allied Sci; 2009 Oct; 64(4):429-73. PubMed ID: 19493917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
    Werling K; Abraham S; Strelec J
    J Health Care Finance; 2007; 34(2):57-70. PubMed ID: 18972994
    [No Abstract]   [Full Text] [Related]  

  • 9. Funding pharmaceutical innovation through direct tax credits.
    Lybecker KM; Freeman RA
    Health Econ Policy Law; 2007 Jul; 2(Pt 3):267-84. PubMed ID: 18634650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deals landscape: notable deals in the pharmaceutical industry in the second quarter of 2008.
    Bright J; Lakeram M
    IDrugs; 2008 Aug; 11(8):584-91. PubMed ID: 18724496
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug access in poor countries].
    Sebbag R
    Bull Acad Natl Med; 2007 Nov; 191(8):1601-2. PubMed ID: 18666459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical firms commit US$1 billion to antibiotic development.
    Mullard A
    Nat Rev Drug Discov; 2020 Sep; 19(9):575-576. PubMed ID: 32788679
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug plundering].
    Velásquez G
    Assist Inferm Ric; 2003; 22(3):182-4. PubMed ID: 14666857
    [No Abstract]   [Full Text] [Related]  

  • 15. Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing.
    Jiang S; Chen Z; Wu T; Wang H
    J Glob Health; 2020 Jun; 10(1):010314. PubMed ID: 32566150
    [No Abstract]   [Full Text] [Related]  

  • 16. Weighing the outcomes.
    Russo MJ; Balekdjian D
    Nat Biotechnol; 2008 Feb; 26(2):173-82. PubMed ID: 18259169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organic synthesis remains relevant in drug discovery.
    Mehrotra MM
    Nature; 2007 Oct; 449(7162):535. PubMed ID: 17914370
    [No Abstract]   [Full Text] [Related]  

  • 18. Excluding NICE from early stages of value based pricing scheme was "big win for pharma," conference is told.
    Limb M
    BMJ; 2013 Nov; 347():f6906. PubMed ID: 24246840
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceutical and other commercial uses of the dog model.
    Ikeda-Douglas CJ; de Rivera C; Milgram NW
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):355-60. PubMed ID: 15795043
    [No Abstract]   [Full Text] [Related]  

  • 20. Pfizer jettisons Esperion.
    Shaffer C
    Nat Biotechnol; 2008 Jul; 26(7):724-5. PubMed ID: 18612282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.